Cardiorentis is Drug Discovery in Switzerland that focus on related cardiovascular diseases business. Founded in 2010. They cover business area such as Provider, bio pharmaceutical service, identification, novel target, its disease-base technology platform, rationally design small molecule compound, peptide, its expertise, protein biology, customer, market, unmet medical need, medication, treatment, heart failure, related cardiovascular disease.
2010
( 14 years old in 2024 )
Related Cardiovascular Diseases
-
Churerstrasse 77
8808 Pfäffikon
Switzerland
Private
Providerbio pharmaceutical serviceidentificationnovel targetits disease-base technology platformrationally design small molecule compoundpeptideits expertiseprotein biologycustomermarketunmet medical needmedicationtreatmentheart failurerelated cardiovascular disease
* We use standard office opening hours in near Cardiorentis's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Cardiorentis is Drug Discovery business from Switzerland that founded in 2010 (14 years old in 2024), Cardiorentis business is focusing on Related Cardiovascular Diseases.
Cardiorentis headquarter office and corporate office address is located in Churerstrasse 77 8808 Pfäffikon Switzerland.
Cardiorentis was founded in Switzerland.
In 2024, Cardiorentis is currently focus on related cardiovascular diseases sector.
Above is snippet of Google Trends for "related cardiovascular diseases" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Cardiorentis, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
